FINWIRES · TerminalLIVE
FINWIRES

Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%

By

Dimerix (ASX:DXB) said it completed the transfer of the investigational new drug application in the US for its acute kidney injury drug candidate, DMX-652, from Mission Therapeutics, according to a Monday Australian bourse filing.

Dimerix plans to advance DMX-652 into a phase 2 clinical trial for acute kidney injury associated with cardiac surgery during the second half, to investigate its potential to prevent kidney injury and preserve renal function.

Its shares jumped 6% in recent trading on Monday.

Related Articles

Asia

Sands China's Attributable Profit Slips 3.6% in H1; Interim Dividend Declared

Sands China (HKG:1928) recorded a 3.6% decline in profit attributable to equity holders in the first half to $398 million from $413 million a year prior.Earnings per share slipped to $0.0492 from $0.051 previously, according to a Friday Hong Kong bourse filing.Net revenue increased 11% to $3.88 billion from $3.49 billion in the year-ago period.The company declared an interim dividend of HK$0.50 per share for the period, payable Oct. 9 to shareholders of record as of Sept. 18.

HKG:1928
Asia

Longfor Warns of Lower H1 Profit

Longfor (HKG:0960) expects profit attributable to owners of between 1.8 billion yuan and 2 billion yuan for the six months ended June 30, down from 3.22 billion yuan a year prior.The property developer attributed the forecast to a continued decline in recognized revenue from the property development business and pressure on the recognized gross profit margin.

HKG:0960
Asia

MCC Logs 447.5 Billion Yuan in January-July New Contract Value

Metallurgical Corp. of China (SHA:601618, HKG:1618), or MCC's, newly-signed contract value for the seven months ended July 31 stood at around 447.5 billion yuan.Of the total, the value of newly-signed overseas contracts reached roughly 39.1 billion yuan, according to a Friday Hong Kong bourse filing.

HKG:1618SHA:601618